Oncology Letters · 2015 · 104 citations · 39 references
Life SciencesMolecular BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingCell Signaling NetworksMalignant NeoplasmsOncogenic Signaling PathwaysRas Family OncogenesTumor Suppressor GenesCellular Cholesterol HomeostasisRas-driven TumorigenesisTumor Suppressor NetworksTumor Suppressor Pathways
-dependent membrane-binding annexin proteins. It participates in membrane and cytoskeleton organization, cholesterol homeostasis, membrane trafficking, cell adhesion and signal transduction. The expression levels of AnxA6 are closely associated with melanoma, cervical cancer, epithelial carcinoma, breast cancer, gastric cancer, prostate cancer, acute lymphoblastic leukemia, chronic myeloid leukemia, large-cell lymphoma and myeloma. AnxA6 exhibits dual functions in cancer, acting either as a tumor suppressor or promoter, depending on the type of cancer and the degree of malignancy. In several types of cancer, AnxA6 acts via Ras, Ras/MAPK and/or FAK/PI3K signaling pathways by mainly mediating PKCα, p120GAP, Bcr-Abl and YY1. In the present review, the roles of AnxA6 in different types of cancer are summarized.
39
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Worldwide burden of cervical cancer in 2008
Marc Arbyn, Xavier Castellsagué, Silvia de Sanjosé et al. · Annals of Oncology · 2011 · 1.1K citations
Medicine, Gynecology, Oncology +14
Early detection and treatment of skin cancer.
Anthony Jerant, Jennifer A. Johnson, Tristan Caffrey · PubMed · 2000 · 318 citations
Medicine, Dermatology, Oncology +17
Early detection and treatment of skin cancer
Peter Trovitch, Anshul Gupte, Kadriye Çiftçi · 2002 · 267 citations
Robert Huber, Monika Schneider, Irmgard Mayr et al. · FEBS Letters · 1990 · 243 citations · Full text